In a study in mice and human cells, Johns Hopkins Medicine researchers say that they have developed a tiny, yet effective method for preventing premature birth. The vaginally-delivered treatment contains nanosized (billionth ...
Jan 13, 2021
0
35
Thousands of different genetic mutations have been implicated in cancer, but a new analysis of almost 10,000 patients found that regardless of the cancer's origin, tumors could be stratified in only 112 subtypes and that, ...
Jan 11, 2021
0
590
A new approach to cancer immunotherapy has the potential to be a universal treatment for solid tumors, according to researchers at Purdue University.
Dec 10, 2020
0
249
In recent years, targeted therapies have cemented their place as some of the most important tools in cancer treatment. These medicines are designed to block specific signals that tumor cells use to grow and spread, while ...
Dec 7, 2020
0
50
Nanoparticles continue to find wider use in medical treatments in everything from drug delivery to diagnosing disease. In nearly every case, these ultrafine particles are delivered to patients via injection or through an ...
Dec 7, 2020
0
124
A COVID-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren't yet hospitalized by the disease but are at high risk.
Nov 22, 2020
0
288
Metformin is a common type 2 diabetes drug. Recently, it was found to extend life span of young non-diabetic animals but the responses of older organisms to metformin remain unexplored. Researchers at the Leibniz Institute ...
Nov 12, 2020
1
302
Through large-scale profiling of protein changes in response to drug treatments in cancer cell lines, researchers at The University of Texas MD Anderson Cancer Center have generated a valuable resource to aid in predicting ...
Nov 5, 2020
0
20
Age may cause identical cancer cells with the same mutations to behave differently. In animal and laboratory models of melanoma cells, age was a primary factor in treatment response.
Nov 2, 2020
0
36
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published today in Nature Communications.
Oct 22, 2020
0
92
